PubRank

Oystein Fodstad

Author PubWeight™ 76.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008 3.11
2 MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 2010 2.85
3 Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. Clin Cancer Res 2006 2.72
4 The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008 1.70
5 Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer. Endocr Relat Cancer 2004 1.67
6 Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol. Mol Cancer 2010 1.50
7 Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 2011 1.49
8 Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling. Pigment Cell Melanoma Res 2007 1.45
9 Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models. Mol Oncol 2009 1.37
10 Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 2004 1.35
11 Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism. Cancer Res 2011 1.35
12 Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res 2008 1.33
13 Matrix metalloproteinases participate in osteosarcoma invasion. J Surg Res 2005 1.32
14 Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev 2009 1.23
15 Deep Sequencing the MicroRNA Transcriptome in Colorectal Cancer. PLoS One 2013 1.22
16 Hematogenous micrometastases in osteosarcoma patients. Clin Cancer Res 2005 1.15
17 B7-H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis-associated genes. Int J Cancer 2011 1.12
18 NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress. Curr Cancer Drug Targets 2008 1.11
19 Epigenetics in human melanoma. Cancer Control 2009 1.09
20 Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer. Clin Colorectal Cancer 2013 1.08
21 The immunoregulatory protein human B7H3 is a tumor-associated antigen that regulates tumor cell migration and invasion. Curr Cancer Drug Targets 2008 1.07
22 Receptor tyrosine kinase ErbB2 translocates into mitochondria and regulates cellular metabolism. Nat Commun 2012 1.06
23 Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS. J Proteome Res 2006 1.06
24 Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide. Clin Cancer Res 2009 1.04
25 B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation. Mol Cancer Ther 2011 1.03
26 Emerging metabolic targets in cancer therapy. Front Biosci (Landmark Ed) 2011 1.02
27 B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer. Int J Cancer 2012 1.01
28 Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models. Invest New Drugs 2010 1.01
29 CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics 2008 1.00
30 S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells. Clin Exp Metastasis 2003 0.98
31 miR-125b functions as a key mediator for snail-induced stem cell propagation and chemoresistance. J Biol Chem 2012 0.98
32 Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines. J Gene Med 2007 0.97
33 Association of insulin-like growth factor binding protein-3 expression with melanoma progression. Mol Cancer Ther 2006 0.97
34 Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7). J Biol Chem 2013 0.95
35 Rac1 activity regulates proliferation of aggressive metastatic melanoma. Exp Cell Res 2007 0.95
36 Com-1/p8 acts as a putative tumour suppressor in prostate cancer. Int J Mol Med 2006 0.94
37 Does the PGC-1/PPARgamma pathway play a role in Com-1/p8 mediated cell growth inhibition in prostate cancer? Int J Mol Med 2006 0.92
38 B7-H3 and its relevance in cancer; immunological and non-immunological perspectives. Front Biosci (Elite Ed) 2011 0.91
39 Primary gene-engineered neural stem/progenitor cells demonstrate tumor-selective migration and antitumor effects in glioma. Int J Cancer 2010 0.90
40 Specific isolation of disseminated cancer cells: a new method permitting sensitive detection of target molecules of diagnostic and therapeutic value. Clin Exp Metastasis 2007 0.90
41 Gamma-glutamylcysteine synthetase-based selection strategy for gene therapy of chronic granulomatous disease and graft-vs.-host disease. Eur J Haematol 2007 0.88
42 Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme. J Neurosurg 2004 0.88
43 Cytoplasmic translocation of p21 mediates NUPR1-induced chemoresistance: NUPR1 and p21 in chemoresistance. FEBS Lett 2012 0.87
44 Bone marrow micrometastases in advanced stage non-small cell lung carcinoma patients. Lung Cancer 2008 0.87
45 Elevated osteopontin levels in metastatic melanoma correlate with epigenetic silencing of breast cancer metastasis suppressor 1. Oncology 2010 0.87
46 Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals. Int J Cancer 2002 0.85
47 Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res 2004 0.85
48 Inhibitory targeting of checkpoint kinase signaling overrides radiation-induced cell cycle gene regulation: a therapeutic strategy in tumor cell radiosensitization? Radiother Oncol 2004 0.85
49 Light-induced adenovirus gene transfer, an efficient and specific gene delivery technology for cancer gene therapy. Cancer Gene Ther 2002 0.85
50 Role of the Multidrug Resistance Protein 1 in protection from heavy metal oxyanions: investigations in vitro and in MRP1-deficient mice. Biochem Biophys Res Commun 2002 0.84
51 Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. J Immunother 2010 0.84
52 Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status. Int J Cancer 2005 0.83
53 Functional characterization of the progestagen-associated endometrial protein gene in human melanoma. J Cell Mol Med 2009 0.83
54 Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. Mol Cancer Ther 2005 0.83
55 Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma. Clin Exp Metastasis 2009 0.83
56 In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Exp Hematol Oncol 2013 0.82
57 Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers. Cancer Gene Ther 2005 0.82
58 Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts. Cancer Genomics Proteomics 2008 0.81
59 Ionizing radiation inhibits the PLK cell cycle gene in a G2 checkpoint-dependent manner. Anticancer Res 2004 0.79
60 Detection of disseminated tumour cells in bone marrow of patients with isolated liver metastases from colorectal cancer. J Surg Oncol 2003 0.79
61 Clinical and cell line specific expression profiles of a human gene identified in experimental central nervous system metastases. Anticancer Res 2002 0.79
62 Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells. Hum Gene Ther 2005 0.78
63 Com-1/P8 in oestrogen regulated growth of breast cancer cells, the ER-beta connection. Biochem Biophys Res Commun 2005 0.78
64 The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells. J Ovarian Res 2014 0.78
65 Triphenylmethyl derivatives enhances the anticancer effect of immunotoxins. J Immunother 2011 0.78
66 The 14-3-3sigma gene promoter is methylated in both human melanocytes and melanoma. BMC Cancer 2009 0.78
67 The transcript expression and protein distribution pattern in human colorectal carcinoma reveal a pivotal role of COM-1/p8 as a tumour suppressor. Cancer Genomics Proteomics 2010 0.77
68 Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. BMC Cancer 2011 0.77
69 Immunotoxins: a promising treatment modality for metastatic melanoma? Ochsner J 2010 0.77
70 Role of the multidrug resistance protein 1 gene in the carcinogenicity of aflatoxin B1: investigations using mrp1-null mice. Toxicology 2002 0.77
71 DNA damage responses in cell cycle G2 phase and mitosis--tracking and targeting. Anticancer Res 2006 0.77
72 The metalloproteinase inhibitor TIMP-2 is down-regulated by androgens in LNCaP prostate carcinoma cells. Clin Exp Metastasis 2003 0.76
73 Antitumor activity of elacytarabine combined with bevacizumab, cetuximab and trastuzumab in human NSCLC xenografts. Anticancer Res 2013 0.75